- Focuses on uterine and endometrial cancers and the impact oncologists can have on the outcome of women diagnosed with these malignancies
- Updated with new chapters on molecular classification of endometrial cancers and hormonal therapies
- Enhances the awareness of this somewhat neglected area of therapeutics
- Helps integrate targeted therapies into the management of women with uterine cancer
- Written by experts in the field in a highly practical and comprehensive manner
- Must-have for all gynecological residents and fellows, gynecological oncologists, medical oncologists, radiation oncologists, and family practice doctors
There are more than 52,000 new cases of uterine and endometrial cancer each year in the United States, up from approximately 41,000 when the first edition of Uterine Cancer was published in 2009. A book focusing on these cancers was timely, with emergent sophistication in diagnosisincreasingly impacting clinical decision-making. However, five years later, the need for an updated book on this topic is even stronger as oncologists recognize opportunities to impact the outcome on women that are increasingly diagnosed with these malignancies. Uterine Cancer:Screening, Diagnosis, and Treatment, Second Edition, part of the Current Clinical Oncology series, enhances the awareness on this somewhat neglected area of therapeutics, helping to integrate targeted therapies into the management of women with uterine cancer. Written by experts inthe field in a highly practical and comprehensive manner, it is a must-have for all gynecological residents and fellows, as well as gynecological oncologists, medical oncologists, radiation oncologists, and family practice doctors who wish to provide their patients with the best possible care.
Dr. Franco Muggia is a professor in the Department of Medicine at the Perlmutter Cancer Center at NYU Langone. His medical expertise include gynecologic cancers, breast cancer, and gynecologic oncology. Dr. Alessandro Santin is a professor of Obstetrics, Gynecology, andReproductive Sciences at Yale School of Medicine. He is also the Clinical Research Program Leader in the Gynecologic Oncology Program at Yale Cancer Center. Dr. Esther Oliva is an Associate Pathologist and Associate Director of Training and Education at Massachusetts General Hospital and an Associate Professor of Pathology at Harvard Medical School.